Frequencies for first 10,000 rows of dose_form variable in drug2016q1 dataset : Form of dose reported | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 6,351 63.51 63.51 CAPLET | 1 0.01 63.52 CAPSULE | 391 3.91 67.43 CAPSULE, HARD | 67 0.67 68.10 CAPSULES | 1 0.01 68.11 CHEWABLE TABLET | 8 0.08 68.19 CONCENTRATE FOR SOLUTION FOR INFUSION | 15 0.15 68.34 CREAM | 4 0.04 68.38 DISPERSIBLE TABLET | 76 0.76 69.14 DROPS | 4 0.04 69.18 EFFERVESCENT TABLET | 6 0.06 69.24 EMULSION FOR INJECTION | 2 0.02 69.26 EXTENDED RELEASE CAPSULES | 1 0.01 69.27 EXTENDED RELEASE TABLET | 2 0.02 69.29 EYE DROPS | 6 0.06 69.35 EYE DROPS, SOLUTION | 5 0.05 69.40 FILM-COATED TABLET | 193 1.93 71.33 FINE GRANULE | 1 0.01 71.34 FORMULATION UNKNOWN | 102 1.02 72.36 GASTRO-RESISTANT CAPSULE, HARD | 3 0.03 72.39 GASTRO-RESISTANT TABLET | 3 0.03 72.42 GEL | 2 0.02 72.44 GRANULES | 6 0.06 72.50 IMPLANT | 5 0.05 72.55 INFUSION | 28 0.28 72.83 INHALATION POWDER | 24 0.24 73.07 INHALATION VAPOUR | 2 0.02 73.09 INHALATION VAPOUR, LIQUID | 2 0.02 73.11 INHALATION VAPOUR, SOLUTION | 3 0.03 73.14 INJECTION | 103 1.03 74.17 INTRAUTERINE DELIVERY SYSTEM | 5 0.05 74.22 INTRAVENOUS INFUSION | 4 0.04 74.26 INVESTIGATIONAL DOSAGE FORM | 1 0.01 74.27 LIPOSOME INJECTION | 1 0.01 74.28 LIQUID | 1 0.01 74.29 LOTION (EXCEPT LOTION FOR EYE) | 1 0.01 74.30 LOZENGE | 1 0.01 74.31 LYOPHILIZED POWDER | 89 0.89 75.20 MODIFIED-RELEASE TABLET | 37 0.37 75.57 NASAL DROP (NASAL SPRAY TOO) | 1 0.01 75.58 NASAL SPRAY | 10 0.10 75.68 NEBULISER SUSPENSION | 4 0.04 75.72 ORAL DROPS | 1 0.01 75.73 ORAL DROPS, SOLUTION | 2 0.02 75.75 ORAL DRUG UNSPECIFIED FORM | 8 0.08 75.83 ORAL POWDER | 1 0.01 75.84 ORAL SOLUTION | 12 0.12 75.96 ORAL SUSPENSION | 9 0.09 76.05 ORODISPERSIBLE TABLET | 11 0.11 76.16 PATCH | 5 0.05 76.21 PER ORAL NOS | 63 0.63 76.84 POWDER | 1 0.01 76.85 POWDER (EXCEPT [DPO]) | 1 0.01 76.86 POWDER AND SOLVENT FOR ORAL SOLUTION | 2 0.02 76.88 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 3 0.03 76.91 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 19 0.19 77.10 POWDER FOR CONCENTRATE FOR SOLUTION F.. | 3 0.03 77.13 POWDER FOR INFUSION | 13 0.13 77.26 POWDER FOR INJECTION | 7 0.07 77.33 POWDER FOR ORAL SOLUTION | 11 0.11 77.44 POWDER FOR SOLUTION FOR INJECTION | 25 0.25 77.69 PROLONGED-RELEASE CAPSULE | 3 0.03 77.72 PROLONGED-RELEASE TABLET | 61 0.61 78.33 SLOW RELEASE CAPSULES | 4 0.04 78.37 SOLUTION | 2 0.02 78.39 SOLUTION FOR INFUSION | 97 0.97 79.36 SOLUTION FOR INJECTION | 215 2.15 81.51 SOLUTION FOR INJECTION IN PRE-FILLED .. | 166 1.66 83.17 SOLUTION FOR INJECTION/INFUSION | 46 0.46 83.63 SPRAY | 1 0.01 83.64 SPRAY (EXCEPT INHALATION) | 1 0.01 83.65 SUPPOSITORY | 10 0.10 83.75 SUSPENSION | 5 0.05 83.80 SUSPENSION FOR INJECTION | 10 0.10 83.90 SYRUP | 1 0.01 83.91 TABLET | 1,490 14.90 98.81 TABLET (EXTENDED RELEASE) | 1 0.01 98.82 TABLETS | 11 0.11 98.93 TAPE (INCLUDING POULTICE) | 2 0.02 98.95 TRANSDERMAL PATCH | 5 0.05 99.00 UNK | 14 0.14 99.14 UNKNOWN | 1 0.01 99.15 UNKNOWN FORMULATION | 6 0.06 99.21 UNSPECIFIED | 78 0.78 99.99 VIAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017